Unique ID issued by UMIN | UMIN000044170 |
---|---|
Receipt number | R000050438 |
Scientific Title | Safety evaluation for combined use of 4 cosmetic preparations |
Date of disclosure of the study information | 2021/05/11 |
Last modified on | 2021/08/31 09:11:25 |
Safety evaluation for combined use of 4 cosmetic preparations
Safety evaluation for combined use of 4 cosmetic preparations
Safety evaluation for combined use of 4 cosmetic preparations
Safety evaluation for combined use of 4 cosmetic preparations
Japan |
Healthy Japanese women between the ages of 30 and 59
Dermatology | Adult |
Others
NO
The purpose is to confirm the safety of 4 test products after combined daily use for 8 weeks.
Safety
Skin findings(Medical examination) : 0-8 weeks
Adverse events : 0-8 weeks
Subjective symptoms(Questionnaire, life diary) : 8 weeks
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Other |
Continuous use every morning and evening for 8 weeks
30 | years-old | <= |
59 | years-old | >= |
Female
1. Healthy Japanese women aged 30 to 59 at the time of screening test
2. A person who has received sufficient explanation about the test product as well as the purpose and content of this research, and then given written consent to participate in the research voluntarily.
1. Persons who have factors that affect the evaluation at the evaluation site including atopic dermatitis, trauma, burns, inflammation, acne, warts, etc.
2. Those who go to the hospital for treatment of an affected area on the face
3. Those who have a history of allergies to cosmetics
4. Those who are receiving hormone replacement therapy
5. Those who are pregnant or breastfeeding, or those who will not use proper birth control because of wishing to become pregnant during the period from the time of giving consent to the end of the study.
6. Those who have received cosmetic medicine that affects the evaluation site, or those who plan to receive it during the research period
7. Those who have undergone special skin care treatment (facial treatment, etc.) that affects the evaluation site within 4 weeks before the start of application of the test product, or those who are planning to receive it during the research period.
8. Those who received the test product in other clinical trials within 4 weeks before the start of application of the test product, or those who plan to participate in other trial during the research period
9. Those who are judged to be ineligible by the principal investigator or investigators with other reasons
30
1st name | Kazuhiko |
Middle name | |
Last name | Takano |
Medical Corporation Hokubukai Utsukushigaoka Hospital
Center for Clinical Pharmacology
004-0839
61-1, Sinei, Kiyota-ku, Sapporo, Hokkaido, 004-0839, Japan
011-882-0111
takano@ughp-cpc.jp
1st name | Takuya |
Middle name | |
Last name | Matsuda |
Medical Corporation Hokubukai Utsukushigaoka Hospital
Center for Clinical Pharmacology
004-0839
61-1, Sinei, Kiyota-ku, Sapporo, Hokkaido, 004-0839, Japan
011-882-0111
matsuda@ughp-cpc.jp
Medical Corporation Hokubukai Utsukushigaoka Hospital
Noevir Co., Ltd.
Profit organization
Medical corporation Hokubukai Utsukushigaoka Hospital Ethics Review Committee
61-1, Sinei, Kiyota-ku, Sapporo, Hokkaido, 004-0839, Japan
011-881-0111
matsuda@ughp-cpc.jp
NO
2021 | Year | 05 | Month | 11 | Day |
Unpublished
Completed
2021 | Year | 04 | Month | 16 | Day |
2021 | Year | 05 | Month | 10 | Day |
2021 | Year | 05 | Month | 17 | Day |
2021 | Year | 07 | Month | 26 | Day |
2021 | Year | 08 | Month | 03 | Day |
2021 | Year | 08 | Month | 03 | Day |
2021 | Year | 08 | Month | 06 | Day |
2021 | Year | 05 | Month | 11 | Day |
2021 | Year | 08 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050438
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |